Reuters logo
1 年前
BRIEF-ProNAi Therapeutics reports interim data from wolverine phase 2 trial
2016年6月6日 / 上午11点17分 / 1 年前

BRIEF-ProNAi Therapeutics reports interim data from wolverine phase 2 trial

June 6 (Reuters) - ProNAi Therapeutics Inc :

* ProNAi Therapeutics Inc reports interim data from wolverine phase 2 trial of PNT2258 in DLBCL

* ProNAi Therapeutics Inc says "do not view these results as robust enough to justify continued development of drug in dlbcl"

* ProNAi Therapeutics Inc says have decided to suspend development of PNT2258 pending further review of these data Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below